News | May 04, 2026
Moderna posts Q1 2026 loss despite revenue surge
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
